UNSPSC 51373334: Bupivacaine/fentanyl

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373334 Bupivacaine/fentanyl is a Commodity code that in recent state and local procurement appears misaligned with actual buying activity — the one recent opportunity flagged under this code solicits naloxone and drug deactivation systems rather than the anesthetic and opioid combination the code nominates. Naloxone is an opioid antagonist used in overdose reversal and falls outside the scope of bupivacaine/fentanyl procurement. The mismatch suggests either a tagging error in the source system or a divergence between the code's nominal scope and how the jurisdiction classified the purchase. No other recent state and local opportunities appear in the available record under this code.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with response due July 26, 2023. The procurement carries a two-year initial term with one-year renewal option and includes standard compliance requirements such as drug-free workplace certification, E-Verify authorization, and specific insurance coverage. The absence of other recent opportunities and the code-scope mismatch signal that bupivacaine/fentanyl procurement activity under this Commodity code currently carries minimal signal for business development purposes in the state and local market.